(OSI) Pharmaceuticals - 2002 Annual Report

	BOARD OF DIRECTORS Robert A. Ingram Chairman of the Board Vice Chairman, Pharmaceuticals GlaxoSmithKline Colin Goddard, Ph.D. Chief Executive Officer Edwin A. Gee, Ph.D. Chairman, Emeritus Former Chairman & CEO International Paper, Inc. Michael G. Atieh Group President Dendrite International G. Morgan Browne Former Chief Financial Officer and Administrative Director Cold Spring Harbor Laboratory John H. French II Vice Chairman Company of the Far Countries Daryl K. Granner, M.D. Director, Vanderbilt Diabetes Center; Professor, Molecular Physiology and Biophysics, Vanderbilt University Walter M. Lovenberg, Ph.D. Former Executive Vice President Marion Merrell Dow Inc. Viren Mehta Mehta Partners LLC Sir Mark Richmond Formerly Head of Research and Special Assignments, Glaxo Research & Development John P. White, Esq. Partner Cooper & Dunham LLP		EXECUTIVE MANAGEMENT COMMITTEE Colin Goddard, Ph.D. Chief Executive Officer Gabriel Leung Executive Vice President and President, Oncology Business Nicole Onetto, M.D. Executive Vice President and Chief Medical Officer Robert L. Van Nostrand Vice President and Chief Financial Officer Barbara A. Wood, Esq. Vice President and General Counsel Robert L. Simon Vice President, Global Regulatory Affairs and CMC Neil Gibson, Ph.D. Vice President, Research Corporate Headquarters OSI Pharmaceuticals, Inc. 58 South Service Road Suite 110 Melville, NY 11747 Other Company Locations OSI Pharmaceuticals (UK) Limited Watlington Road Oxford, OX4 6LT United Kingdom OSI Pharmaceuticals (Boulder) 2860 Wilderness Place Boulder, CO 80301 OSI Pharmaceuticals (US Research) 1 Bioscience Park Drive Farmingdale, NY 11735 Transfer Agent & Registrar Bank of New York 101 Barclay Street New York, NY 10286 (800) 524-4458 http://stock.bankofny.com		Corporate Counsel Saul Ewing LLP Centre Square West 1500 Market Street Philadelphia, PA 19102 General Counsel Mintz, Levin 666 Third Avenue New York, NY 10017 Patent Counsel Cooper & Dunham LLP 1185 Avenue of The Americas New York, NY 10036 Auditors KPMG LLP 1305 Walt Whitman Road Melville, NY 11747 Annual Meeting The annual meeting of shareholders will be held on March 17, 2004 at 10:00AM at: OSI Pharmaceuticals, Inc. Corporate Headquarters 58 South Service Road Melville, New York 11747 Annual Report on Form 10-K The Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission and other information may be obtained without charge by writing, phoning or visiting our website: OSI Pharmaceuticals, Inc. 58 South Service Road Suite 110 Melville, NY 11747 (631) 962-2000 www.osip.com Stock Listing Nasdaq: OSIP Copyright © 2004 OSI Pharmaceuticals, Inc. All Rights Reserved. Design: Ross Culbert & Lavery, Inc. www.rclnyc.com Portrait Photography: Mark Asnin, Peter Vidor, Dwight Cendrowski